BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19339935)

  • 1. Stem cell transplantation in HIV-infected patients.
    Krishnan A
    Curr Opin HIV AIDS; 2009 Jan; 4(1):11-5. PubMed ID: 19339935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation for AIDS-related malignancies.
    Krishnan A; Forman SJ
    Curr Opin Oncol; 2010 Sep; 22(5):456-60. PubMed ID: 20639760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood and marrow transplant for lymphoma patients with HIV/AIDS.
    Wagner-Johnston ND; Ambinder RF
    Curr Opin Oncol; 2008 Mar; 20(2):201-5. PubMed ID: 18300771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation in patients infected with HIV.
    Serrano D; Miralles P; Balsalobre P; Díez-Martin JL; Berenguer J
    Curr HIV/AIDS Rep; 2010 Aug; 7(3):175-84. PubMed ID: 20549392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center.
    Molina A; Popplewell L; Kashyap A; Nademanee A
    Clin Transpl; 2000; ():317-42. PubMed ID: 11512326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease.
    Gabriel I; Apperley J; Bower M; Chaidos A; Gazzard B; Giles C; Kew A; Nelson M; Kanfer E
    AIDS; 2008 Feb; 22(4):539-40. PubMed ID: 18301069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing treatment of HIV-associated lymphoma.
    Noy A
    Blood; 2019 Oct; 134(17):1385-1394. PubMed ID: 30992269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation.
    Molina A; Zaia J; Krishnan A
    Blood Rev; 2003 Dec; 17(4):249-58. PubMed ID: 14556780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous stem cell transplantation for HIV-associated lymphoma.
    Krishnan A; Molina A; Zaia J; Nademanee A; Kogut N; Rosenthal J; Woo D; Forman SJ
    Blood; 2001 Dec; 98(13):3857-9. PubMed ID: 11739198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
    Pippi F
    Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia.
    Sorà F; Antinori A; Piccirillo N; De Luca A; Chiusolo P; Cingolani A; Laurenti L; Rutella S; Ortona L; Leone G; Sica S
    Exp Hematol; 2002 Mar; 30(3):279-84. PubMed ID: 11882366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose therapy and autologous stem cell transplantation for children with HIV-associated non-Hodgkin lymphoma.
    Fluri S; Ammann R; Lüthy AR; Hirt A; Aebi C; Duppenthaler A; Leibundgut K
    Pediatr Blood Cancer; 2007 Dec; 49(7):984-7. PubMed ID: 16685736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation.
    Pratesi C; Simonelli C; Zanussi S; Talamini R; Bortolin MT; Tedeschi R; Marus A; Caffau C; Michieli M; Tirelli U; De Paoli P
    Clin Exp Immunol; 2008 Jan; 151(1):101-9. PubMed ID: 17931391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
    Re A; Cattaneo C; Michieli M; Casari S; Spina M; Rupolo M; Allione B; Nosari A; Schiantarelli C; Vigano M; Izzi I; Ferremi P; Lanfranchi A; Mazzuccato M; Carosi G; Tirelli U; Rossi G
    J Clin Oncol; 2003 Dec; 21(23):4423-7. PubMed ID: 14581441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial.
    Shindiapina P; Pietrzak M; Seweryn M; McLaughlin E; Zhang X; Makowski M; Ahmed EH; Schlotter S; Pearson R; Kitzler R; Mozhenkova A; Le-Rademacher J; Little RF; Akpek G; Ayala E; Devine SM; Kaplan LD; Noy A; Popat UR; Hsu JW; Morris LE; Mendizabal AM; Krishnan A; Wachsman W; Williams N; Sharma N; Hofmeister CC; Forman SJ; Navarro WH; Alvarnas JC; Ambinder RF; Lozanski G; Baiocchi RA
    Front Immunol; 2021; 12():700045. PubMed ID: 34539628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need.
    Shimoni A; Nagler A
    Best Pract Res Clin Haematol; 2011 Sep; 24(3):369-79. PubMed ID: 21925090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
    Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2039-2051. PubMed ID: 26428082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can.
    Hamadani M; Devine SM
    Blood; 2009 Sep; 114(12):2564-6. PubMed ID: 19762505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.